COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04952350


Column Value
Trial registration number NCT04952350
Full text link
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov

Moataz M Emara

Contact
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov

mm.emara@mans.edu.eg

Registration date
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

2021-07-07

Recruitment status
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Not recruiting

Study design
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

inclusion criteria: - we will include adult patients (≥18 years old) with severe and critical covid19 admitted to the covid19 mansoura university isolation hospital. we will include patients who are pcr-confirmed, clinically or radiologically diagnosed with covid19. cases are defined as severe or critical according to the who definition (19); where critical cases have ards, or sepsis, septic shock or pulmonary embolism, acute coronary syndrome, or acute stroke, while severe cases have the clinical signs of severe pneumonia and spo2 <90% on room air, or rr <30 breaths/min without any critical criteria.

Exclusion criteria
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

- chronic statin use, serum creatine kinase (sr ck) > 5 times the upper limit of normal (uln), serum transaminases > 5 times uln, acute hepatic failure, chronic liver disease (child-pugh classification c), history of rhabdomyolysis or myopathies, severe renal impairment not receiving renal replacement therapy (estimated cr cl< 30 ml\min ), pregnant and lactating women, patients who are expected to die within 48 hours, or patients on chronic colchicine, cyclosporines, or ritonavir.

Number of arms
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Mansoura University

Inclusion age min
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov

Egypt

Type of patients
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Severe/critical disease at enrollment

Severity scale
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

7: Severe/critical disease at enrollment

Total sample size
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

220

primary outcome
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

mortality;mortality

Notes
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Phase 3

Arms
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 137, "treatment_name": "Atorvastatin", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]